Gilead Sciences (GILD) Ratings, Price Targets

Gilead Sciences (NASDAQ: GILD) ratings and price targets.

Needham & Company reiterated its "Buy" rating on Gilead Sciences (NASDAQ: GILD) today.

Citigroup (NYSE: C) reiterated a “Buy” rating on Gilead Sciences earlier in the week. They have a price target of $49.00 on the company.

JPMorgan Chase & Co. (NYSE: JPM) reiterated an "Overweight" rating on Gilead Sciences.

Oppenheimer (NYSE: OPY) boosted its price target on Gilead Sciences to $47.00. They have an "Outperform" rating on the company.

Gilead was trading at $42.83, gaining $0.31, or 0.74 percent, as of 11:59 AM EST.